
Germany Scraps Variable Drug Discount Plan After Industry Backlash
Facing fierce resistance from pharmaceutical giants, the German government is abandoning its proposal to introduce variable drug discounts. Officials are now pivoting to a fixed-discount model, hoping to stabilize the industry’s investment climate while still addressing a massive 20-billion-euro shortfall in the national healthcare system.























